Paper Contents
Abstract
The advent of three-dimensional (3D) printing technology in medicine allows the pharmaceutical sector to participate in the fourth industrial revolution. 3D printing technology is a groundbreaking and essential method for fabricating solid objects through the layer-by-layer deposition process under computer supervision. Three-dimensional (3D) printed medicines may serve as an essential instrument for comprehending individualized treatments tailored to the distinct needs of each patient, encompassing factors such as age, weight, co-morbidities, and pharmacogenetic and pharmacokinetic attributes. 3D printing technology provides a distinct advantage over traditional methods in the domain of new drug delivery systems (NDDS). Many 3D printing techniques utilized encompass inkjet printers, thermal inkjet printers, fused deposition modeling, and hot melt extrusion, among others. The uses of 3D printing in the pharmaceutical sector are many, including lab-grown organs, drug delivery systems, anatomical models, and customized medications, among others.3D printing is considered a valuable, efficient, and economical instrument with the capacity to transform the future of general pharmacy practice, particularly in pharmacological therapy.
Copyright
Copyright © 2025 Vaibhav S. Shikare. This is an open access article distributed under the Creative Commons Attribution License.
